Another possibility is the presence of an assorted form of MIC-1 that may vary according to tumor type, stage and its progression and intracellular processing of MIC-1 that eventually manages the ratio of MIC-1 to remain localized in tumor microenvironments and diffused into circulation. The gene discussed is GDF15; the disease is neoplasm.